 John Carroll
Concepts (435)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transcatheter Aortic Valve Replacement | 53 | 2023 | 151 | 14.290 |
Why?
| | Foramen Ovale, Patent | 33 | 2024 | 45 | 11.420 |
Why?
| | Cardiac Catheterization | 57 | 2024 | 541 | 11.170 |
Why?
| | Aortic Valve Stenosis | 45 | 2023 | 295 | 9.440 |
Why?
| | Coronary Angiography | 31 | 2020 | 311 | 6.600 |
Why?
| | Heart Valve Prosthesis Implantation | 25 | 2023 | 189 | 6.550 |
Why?
| | Septal Occluder Device | 21 | 2021 | 47 | 6.060 |
Why?
| | Heart Valve Prosthesis | 20 | 2022 | 125 | 5.400 |
Why?
| | Stroke | 33 | 2024 | 1047 | 5.080 |
Why?
| | Echocardiography, Transesophageal | 18 | 2021 | 89 | 4.990 |
Why?
| | Echocardiography, Three-Dimensional | 12 | 2019 | 53 | 4.890 |
Why?
| | Aortic Valve | 35 | 2023 | 401 | 4.310 |
Why?
| | Heart Septal Defects, Atrial | 11 | 2020 | 50 | 3.840 |
Why?
| | Mitral Valve | 16 | 2023 | 91 | 3.700 |
Why?
| | Imaging, Three-Dimensional | 24 | 2019 | 499 | 3.660 |
Why?
| | Registries | 35 | 2023 | 1810 | 3.550 |
Why?
| | Mitral Valve Insufficiency | 12 | 2023 | 62 | 3.450 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 16 | 2019 | 109 | 3.340 |
Why?
| | Radiography, Interventional | 13 | 2020 | 113 | 3.290 |
Why?
| | Heart Valve Diseases | 14 | 2019 | 135 | 2.930 |
Why?
| | Ultrasonography, Interventional | 10 | 2020 | 155 | 2.810 |
Why?
| | Secondary Prevention | 13 | 2024 | 227 | 2.630 |
Why?
| | Treatment Outcome | 76 | 2024 | 9342 | 2.540 |
Why?
| | Echocardiography, Doppler, Color | 8 | 2019 | 38 | 2.220 |
Why?
| | Embolism, Paradoxical | 7 | 2020 | 7 | 1.910 |
Why?
| | Angioplasty, Balloon, Coronary | 13 | 2010 | 148 | 1.780 |
Why?
| | Heart Defects, Congenital | 8 | 2020 | 703 | 1.730 |
Why?
| | Fluoroscopy | 10 | 2021 | 146 | 1.720 |
Why?
| | Cardiac Surgical Procedures | 8 | 2023 | 461 | 1.700 |
Why?
| | Humans | 189 | 2024 | 118972 | 1.590 |
Why?
| | Prosthesis Implantation | 6 | 2019 | 141 | 1.530 |
Why?
| | Coronary Artery Disease | 11 | 2011 | 647 | 1.510 |
Why?
| | Cardiology | 13 | 2023 | 272 | 1.460 |
Why?
| | Thoracic Surgery | 10 | 2021 | 120 | 1.360 |
Why?
| | Heart Diseases | 5 | 2019 | 341 | 1.340 |
Why?
| | Stents | 16 | 2011 | 457 | 1.320 |
Why?
| | Catheterization | 8 | 2010 | 163 | 1.300 |
Why?
| | Predictive Value of Tests | 20 | 2019 | 1868 | 1.300 |
Why?
| | Iatrogenic Disease | 3 | 2018 | 49 | 1.230 |
Why?
| | Heart Injuries | 4 | 2018 | 38 | 1.220 |
Why?
| | Coronary Vessels | 8 | 2010 | 233 | 1.210 |
Why?
| | Prostheses and Implants | 6 | 2013 | 141 | 1.200 |
Why?
| | Cineangiography | 7 | 2009 | 17 | 1.200 |
Why?
| | Hypoxia | 4 | 2020 | 963 | 1.190 |
Why?
| | Risk Factors | 40 | 2023 | 9000 | 1.150 |
Why?
| | Image Enhancement | 3 | 2013 | 181 | 1.080 |
Why?
| | Societies, Medical | 9 | 2020 | 703 | 1.080 |
Why?
| | Radiation Dosage | 8 | 2016 | 147 | 1.060 |
Why?
| | Image Processing, Computer-Assisted | 8 | 2015 | 709 | 1.050 |
Why?
| | Platelet Aggregation Inhibitors | 10 | 2024 | 402 | 1.050 |
Why?
| | Mitral Valve Stenosis | 4 | 2016 | 21 | 1.040 |
Why?
| | Aged, 80 and over | 35 | 2022 | 6561 | 1.040 |
Why?
| | Aged | 60 | 2023 | 19657 | 1.040 |
Why?
| | Ischemic Attack, Transient | 3 | 2015 | 62 | 1.030 |
Why?
| | Prosthesis Failure | 5 | 2020 | 120 | 1.010 |
Why?
| | Male | 90 | 2023 | 57801 | 1.010 |
Why?
| | Prosthesis Design | 13 | 2019 | 285 | 0.990 |
Why?
| | Coronary Stenosis | 3 | 2010 | 39 | 0.950 |
Why?
| | Sodium Chloride | 2 | 2015 | 144 | 0.940 |
Why?
| | Fibrinolytic Agents | 6 | 2022 | 238 | 0.930 |
Why?
| | Contrast Media | 6 | 2015 | 373 | 0.910 |
Why?
| | Multimodal Imaging | 3 | 2020 | 100 | 0.890 |
Why?
| | Percutaneous Coronary Intervention | 2 | 2020 | 455 | 0.880 |
Why?
| | Intracranial Embolism | 1 | 2022 | 27 | 0.870 |
Why?
| | Female | 82 | 2023 | 61564 | 0.870 |
Why?
| | United States | 42 | 2023 | 12555 | 0.850 |
Why?
| | Tomography, X-Ray Computed | 9 | 2020 | 2436 | 0.840 |
Why?
| | Technology Transfer | 1 | 2021 | 13 | 0.820 |
Why?
| | Time Factors | 20 | 2022 | 6412 | 0.780 |
Why?
| | Randomized Controlled Trials as Topic | 10 | 2021 | 1244 | 0.770 |
Why?
| | Device Removal | 4 | 2012 | 127 | 0.760 |
Why?
| | Computed Tomography Angiography | 3 | 2020 | 81 | 0.760 |
Why?
| | Risk Assessment | 17 | 2021 | 3057 | 0.740 |
Why?
| | Embolism | 3 | 2019 | 43 | 0.730 |
Why?
| | Echocardiography | 9 | 2020 | 556 | 0.720 |
Why?
| | Postoperative Complications | 11 | 2021 | 2235 | 0.700 |
Why?
| | Surgery, Computer-Assisted | 4 | 2009 | 69 | 0.700 |
Why?
| | Coronary Occlusion | 1 | 2019 | 18 | 0.700 |
Why?
| | Migraine Disorders | 4 | 2021 | 79 | 0.690 |
Why?
| | Mitral Valve Annuloplasty | 1 | 2019 | 3 | 0.690 |
Why?
| | Lacerations | 1 | 2019 | 30 | 0.690 |
Why?
| | Middle Aged | 43 | 2022 | 27617 | 0.680 |
Why?
| | Dyspnea | 1 | 2020 | 201 | 0.680 |
Why?
| | Product Surveillance, Postmarketing | 4 | 2015 | 64 | 0.680 |
Why?
| | Shock, Cardiogenic | 1 | 2019 | 53 | 0.670 |
Why?
| | Atrial Fibrillation | 4 | 2020 | 338 | 0.660 |
Why?
| | Technology Assessment, Biomedical | 2 | 2015 | 29 | 0.660 |
Why?
| | Balloon Occlusion | 3 | 2014 | 26 | 0.650 |
Why?
| | Thrombosis | 4 | 2012 | 309 | 0.630 |
Why?
| | Patient Selection | 10 | 2019 | 676 | 0.620 |
Why?
| | Inferior Wall Myocardial Infarction | 1 | 2017 | 2 | 0.620 |
Why?
| | Heart Rupture, Post-Infarction | 1 | 2017 | 3 | 0.620 |
Why?
| | Papillary Muscles | 1 | 2017 | 13 | 0.610 |
Why?
| | Models, Cardiovascular | 3 | 2008 | 180 | 0.590 |
Why?
| | Radiographic Image Enhancement | 4 | 2009 | 65 | 0.580 |
Why?
| | Therapy, Computer-Assisted | 2 | 2014 | 60 | 0.580 |
Why?
| | Aorta | 3 | 2009 | 367 | 0.580 |
Why?
| | ST Elevation Myocardial Infarction | 1 | 2017 | 51 | 0.570 |
Why?
| | Medicare | 8 | 2023 | 663 | 0.570 |
Why?
| | Surgeons | 4 | 2022 | 243 | 0.570 |
Why?
| | Multidetector Computed Tomography | 1 | 2016 | 27 | 0.560 |
Why?
| | Severity of Illness Index | 11 | 2021 | 2674 | 0.560 |
Why?
| | Aortography | 1 | 2016 | 52 | 0.550 |
Why?
| | Diagnostic Imaging | 3 | 2010 | 294 | 0.550 |
Why?
| | Heart Ventricles | 3 | 2018 | 727 | 0.550 |
Why?
| | Echocardiography, Stress | 1 | 2015 | 21 | 0.540 |
Why?
| | Exercise Test | 3 | 2015 | 551 | 0.540 |
Why?
| | Consensus | 9 | 2021 | 534 | 0.530 |
Why?
| | Aortic Valve Insufficiency | 1 | 2015 | 42 | 0.520 |
Why?
| | Fistula | 2 | 2022 | 27 | 0.510 |
Why?
| | Embolization, Therapeutic | 2 | 2007 | 192 | 0.500 |
Why?
| | Retrospective Studies | 21 | 2021 | 12978 | 0.500 |
Why?
| | Foreign-Body Migration | 2 | 2012 | 37 | 0.500 |
Why?
| | Radiation Injuries | 1 | 2015 | 131 | 0.490 |
Why?
| | Reoperation | 6 | 2021 | 557 | 0.490 |
Why?
| | Heart Septal Defects, Ventricular | 3 | 2009 | 43 | 0.490 |
Why?
| | Health Policy | 1 | 2017 | 333 | 0.490 |
Why?
| | Heart Septal Defects | 3 | 2008 | 10 | 0.480 |
Why?
| | Hospital Mortality | 11 | 2021 | 814 | 0.480 |
Why?
| | Balloon Valvuloplasty | 1 | 2013 | 3 | 0.470 |
Why?
| | Incidence | 10 | 2021 | 2424 | 0.440 |
Why?
| | Surgical Instruments | 1 | 2012 | 49 | 0.430 |
Why?
| | Reproducibility of Results | 12 | 2021 | 2874 | 0.430 |
Why?
| | Aortic Rupture | 1 | 2012 | 26 | 0.420 |
Why?
| | Triiodobenzoic Acids | 2 | 2011 | 13 | 0.410 |
Why?
| | Myocardial Infarction | 8 | 2008 | 968 | 0.410 |
Why?
| | Adult | 27 | 2023 | 31512 | 0.410 |
Why?
| | Models, Anatomic | 2 | 2009 | 94 | 0.400 |
Why?
| | Prospective Studies | 14 | 2023 | 6471 | 0.400 |
Why?
| | Coronary Restenosis | 2 | 2009 | 18 | 0.400 |
Why?
| | Catheter Ablation | 2 | 2018 | 286 | 0.400 |
Why?
| | Sensitivity and Specificity | 7 | 2019 | 1795 | 0.390 |
Why?
| | Heart Atria | 5 | 2012 | 112 | 0.390 |
Why?
| | Angiography | 4 | 2019 | 185 | 0.380 |
Why?
| | Computer Simulation | 4 | 2008 | 922 | 0.380 |
Why?
| | Coronary Disease | 3 | 2009 | 356 | 0.370 |
Why?
| | Equipment Design | 5 | 2014 | 519 | 0.370 |
Why?
| | Follow-Up Studies | 14 | 2019 | 4596 | 0.360 |
Why?
| | Algorithms | 7 | 2010 | 1541 | 0.350 |
Why?
| | Coronary Thrombosis | 1 | 2009 | 25 | 0.350 |
Why?
| | Angiocardiography | 1 | 2009 | 1 | 0.350 |
Why?
| | Rotation | 4 | 2011 | 121 | 0.340 |
Why?
| | Anticoagulants | 4 | 2021 | 559 | 0.340 |
Why?
| | Evidence-Based Medicine | 4 | 2019 | 693 | 0.340 |
Why?
| | Myocardial Revascularization | 1 | 2009 | 72 | 0.330 |
Why?
| | Oxygen | 1 | 2013 | 854 | 0.330 |
Why?
| | Survival Rate | 12 | 2021 | 1720 | 0.330 |
Why?
| | Clinical Decision-Making | 4 | 2019 | 278 | 0.330 |
Why?
| | Stroke Volume | 2 | 2009 | 512 | 0.330 |
Why?
| | Drug-Eluting Stents | 1 | 2009 | 66 | 0.330 |
Why?
| | Recurrence | 7 | 2022 | 975 | 0.320 |
Why?
| | Migraine with Aura | 1 | 2008 | 10 | 0.320 |
Why?
| | Echocardiography, Doppler | 1 | 2008 | 95 | 0.320 |
Why?
| | Heart Septum | 1 | 2008 | 28 | 0.320 |
Why?
| | Ventricular Septum | 1 | 2007 | 10 | 0.320 |
Why?
| | Practice Guidelines as Topic | 5 | 2019 | 1440 | 0.320 |
Why?
| | Patient Simulation | 1 | 2008 | 30 | 0.310 |
Why?
| | Monitoring, Intraoperative | 1 | 2007 | 43 | 0.310 |
Why?
| | Coronary Artery Bypass | 1 | 2009 | 209 | 0.300 |
Why?
| | Health Status | 3 | 2021 | 726 | 0.300 |
Why?
| | Pericardium | 1 | 2007 | 50 | 0.300 |
Why?
| | Hemodynamics | 6 | 2020 | 1003 | 0.300 |
Why?
| | Hemostatic Techniques | 1 | 2007 | 40 | 0.300 |
Why?
| | Catheters, Indwelling | 1 | 2007 | 81 | 0.300 |
Why?
| | Clinical Competence | 6 | 2019 | 951 | 0.290 |
Why?
| | Advisory Committees | 2 | 2018 | 212 | 0.290 |
Why?
| | Comprehension | 1 | 2008 | 163 | 0.280 |
Why?
| | Hemorrhage | 4 | 2018 | 623 | 0.280 |
Why?
| | Wounds, Penetrating | 1 | 2007 | 77 | 0.280 |
Why?
| | Cohort Studies | 7 | 2023 | 5116 | 0.280 |
Why?
| | Patient Readmission | 4 | 2019 | 634 | 0.270 |
Why?
| | Recovery of Function | 3 | 2019 | 604 | 0.270 |
Why?
| | Equipment Failure | 3 | 2012 | 114 | 0.270 |
Why?
| | Aortic Diseases | 1 | 2007 | 94 | 0.270 |
Why?
| | Ischemia | 1 | 2009 | 374 | 0.270 |
Why?
| | Ventricular Function, Left | 1 | 2009 | 468 | 0.270 |
Why?
| | Immunoglobulin Fab Fragments | 6 | 2008 | 69 | 0.270 |
Why?
| | Blood Vessel Prosthesis | 1 | 2006 | 115 | 0.260 |
Why?
| | Aneurysm, False | 1 | 2005 | 46 | 0.260 |
Why?
| | N-Acetylmuramoyl-L-alanine Amidase | 1 | 2004 | 8 | 0.260 |
Why?
| | Aortic Aneurysm | 1 | 2005 | 51 | 0.260 |
Why?
| | Education, Medical | 1 | 2008 | 239 | 0.250 |
Why?
| | Equipment Safety | 1 | 2004 | 38 | 0.250 |
Why?
| | Healthcare Disparities | 2 | 2020 | 496 | 0.240 |
Why?
| | Antibodies, Antiphospholipid | 1 | 2004 | 22 | 0.240 |
Why?
| | Antiphospholipid Syndrome | 1 | 2004 | 29 | 0.240 |
Why?
| | Anatomy, Cross-Sectional | 1 | 2003 | 12 | 0.230 |
Why?
| | Magnetic Resonance Angiography | 1 | 2005 | 210 | 0.230 |
Why?
| | Automation | 2 | 2016 | 77 | 0.220 |
Why?
| | Practice Patterns, Physicians' | 3 | 2019 | 1200 | 0.220 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2006 | 374 | 0.220 |
Why?
| | Aspirin | 3 | 2020 | 334 | 0.220 |
Why?
| | Embolic Protection Devices | 1 | 2022 | 10 | 0.220 |
Why?
| | Aneurysm | 1 | 2022 | 32 | 0.220 |
Why?
| | Pacemaker, Artificial | 2 | 2020 | 105 | 0.210 |
Why?
| | Hospitals, High-Volume | 2 | 2019 | 42 | 0.210 |
Why?
| | Multicenter Studies as Topic | 5 | 2023 | 253 | 0.210 |
Why?
| | Prognosis | 5 | 2021 | 3443 | 0.210 |
Why?
| | Quality of Health Care | 3 | 2019 | 586 | 0.210 |
Why?
| | Renal Insufficiency | 1 | 2003 | 150 | 0.200 |
Why?
| | Arteries | 1 | 2003 | 250 | 0.200 |
Why?
| | Mycobacterium tuberculosis | 1 | 2004 | 266 | 0.200 |
Why?
| | Decompression Sickness | 1 | 2021 | 2 | 0.200 |
Why?
| | Cost-Benefit Analysis | 3 | 2019 | 554 | 0.200 |
Why?
| | Learning Curve | 2 | 2019 | 67 | 0.200 |
Why?
| | Health Resources | 2 | 2019 | 132 | 0.200 |
Why?
| | Observer Variation | 3 | 2011 | 309 | 0.190 |
Why?
| | Minimally Invasive Surgical Procedures | 2 | 2014 | 158 | 0.190 |
Why?
| | Cardiovascular Agents | 3 | 2014 | 126 | 0.190 |
Why?
| | Colorado | 4 | 2019 | 4196 | 0.190 |
Why?
| | American Heart Association | 2 | 2019 | 270 | 0.190 |
Why?
| | Thromboembolism | 1 | 2021 | 99 | 0.190 |
Why?
| | Image Interpretation, Computer-Assisted | 2 | 2015 | 220 | 0.180 |
Why?
| | Databases, Factual | 3 | 2020 | 1231 | 0.180 |
Why?
| | Rural Health Services | 1 | 2020 | 93 | 0.180 |
Why?
| | Computer Systems | 2 | 2009 | 47 | 0.180 |
Why?
| | Delivery of Health Care, Integrated | 2 | 2019 | 233 | 0.180 |
Why?
| | Pattern Recognition, Automated | 3 | 2010 | 76 | 0.170 |
Why?
| | Neurologists | 1 | 2019 | 19 | 0.170 |
Why?
| | Hospitals, Low-Volume | 1 | 2019 | 23 | 0.170 |
Why?
| | Electrocardiography, Ambulatory | 1 | 2019 | 53 | 0.170 |
Why?
| | Comparative Effectiveness Research | 1 | 2020 | 132 | 0.170 |
Why?
| | Antibodies, Monoclonal | 6 | 2008 | 1284 | 0.170 |
Why?
| | Popliteal Artery | 2 | 2009 | 59 | 0.170 |
Why?
| | Magnetic Resonance Imaging | 2 | 2007 | 3174 | 0.170 |
Why?
| | Atrioventricular Block | 1 | 2019 | 33 | 0.170 |
Why?
| | Cardiopulmonary Bypass | 1 | 2020 | 203 | 0.170 |
Why?
| | Anatomic Landmarks | 1 | 2019 | 28 | 0.170 |
Why?
| | Hospital Costs | 1 | 2019 | 110 | 0.170 |
Why?
| | Heart Valves | 1 | 2019 | 44 | 0.170 |
Why?
| | Patient-Specific Modeling | 1 | 2019 | 37 | 0.170 |
Why?
| | Length of Stay | 3 | 2020 | 1032 | 0.170 |
Why?
| | Treatment Failure | 3 | 2009 | 341 | 0.170 |
Why?
| | Young Adult | 6 | 2021 | 10793 | 0.170 |
Why?
| | Angiotensin Receptor Antagonists | 1 | 2018 | 84 | 0.160 |
Why?
| | Software | 2 | 2016 | 613 | 0.160 |
Why?
| | Angioplasty, Balloon | 2 | 2011 | 88 | 0.160 |
Why?
| | Bioprosthesis | 1 | 2018 | 36 | 0.160 |
Why?
| | Models, Organizational | 2 | 2019 | 146 | 0.160 |
Why?
| | Heart Block | 1 | 2018 | 37 | 0.160 |
Why?
| | Diagnostic Errors | 2 | 2010 | 162 | 0.160 |
Why?
| | Risk | 3 | 2019 | 853 | 0.160 |
Why?
| | Proportional Hazards Models | 3 | 2019 | 1125 | 0.160 |
Why?
| | Coronary Circulation | 2 | 2007 | 121 | 0.150 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2018 | 195 | 0.150 |
Why?
| | Disease Management | 2 | 2021 | 571 | 0.150 |
Why?
| | Intention to Treat Analysis | 2 | 2017 | 70 | 0.150 |
Why?
| | Research Report | 1 | 2017 | 75 | 0.150 |
Why?
| | France | 1 | 2016 | 35 | 0.150 |
Why?
| | Single-Blind Method | 2 | 2017 | 269 | 0.140 |
Why?
| | Personal Satisfaction | 1 | 2018 | 188 | 0.140 |
Why?
| | Patient Safety | 2 | 2019 | 281 | 0.140 |
Why?
| | Tachycardia, Ventricular | 1 | 2018 | 151 | 0.140 |
Why?
| | Radiologic Health | 1 | 2015 | 5 | 0.140 |
Why?
| | Atrial Pressure | 1 | 2015 | 5 | 0.140 |
Why?
| | Netherlands | 1 | 2015 | 62 | 0.140 |
Why?
| | Radiation Exposure | 1 | 2016 | 44 | 0.140 |
Why?
| | Atrial Function, Right | 1 | 2015 | 15 | 0.140 |
Why?
| | Valsalva Maneuver | 1 | 2015 | 12 | 0.140 |
Why?
| | Adolescent | 6 | 2021 | 18480 | 0.130 |
Why?
| | Movement | 2 | 2009 | 248 | 0.130 |
Why?
| | Heart Rate | 2 | 2011 | 729 | 0.130 |
Why?
| | Pulmonary Wedge Pressure | 1 | 2015 | 65 | 0.130 |
Why?
| | Education, Medical, Graduate | 1 | 2019 | 399 | 0.130 |
Why?
| | Area Under Curve | 1 | 2015 | 296 | 0.130 |
Why?
| | Intersectoral Collaboration | 1 | 2015 | 60 | 0.130 |
Why?
| | Patient Care Team | 1 | 2019 | 521 | 0.120 |
Why?
| | Clinical Protocols | 1 | 2015 | 238 | 0.120 |
Why?
| | Health Services Accessibility | 1 | 2020 | 781 | 0.120 |
Why?
| | Four-Dimensional Computed Tomography | 1 | 2014 | 27 | 0.120 |
Why?
| | Cardiac Catheters | 1 | 2013 | 14 | 0.120 |
Why?
| | ROC Curve | 1 | 2015 | 473 | 0.120 |
Why?
| | Atrial Septum | 1 | 2013 | 3 | 0.120 |
Why?
| | Ultrasonography | 2 | 2008 | 716 | 0.120 |
Why?
| | Kidney Failure, Chronic | 1 | 2019 | 516 | 0.120 |
Why?
| | Punctures | 1 | 2013 | 39 | 0.120 |
Why?
| | X-Rays | 2 | 2010 | 26 | 0.120 |
Why?
| | Global Health | 1 | 2016 | 310 | 0.120 |
Why?
| | Societies | 1 | 2013 | 42 | 0.110 |
Why?
| | Propensity Score | 3 | 2019 | 242 | 0.110 |
Why?
| | Hospitals | 1 | 2017 | 598 | 0.110 |
Why?
| | Femoral Artery | 2 | 2013 | 175 | 0.110 |
Why?
| | Forecasting | 2 | 2016 | 353 | 0.110 |
Why?
| | United States Food and Drug Administration | 1 | 2013 | 175 | 0.110 |
Why?
| | Blood Pressure | 2 | 2011 | 1664 | 0.110 |
Why?
| | Cardiovascular Diseases | 1 | 2004 | 1798 | 0.110 |
Why?
| | Models, Statistical | 1 | 2016 | 636 | 0.100 |
Why?
| | Research Design | 1 | 2018 | 969 | 0.100 |
Why?
| | Quality Improvement | 2 | 2019 | 963 | 0.100 |
Why?
| | Blood Vessel Prosthesis Implantation | 2 | 2004 | 181 | 0.100 |
Why?
| | Electrocardiography | 2 | 2014 | 556 | 0.100 |
Why?
| | Europe | 2 | 2009 | 356 | 0.100 |
Why?
| | Stress, Mechanical | 2 | 2003 | 443 | 0.100 |
Why?
| | Automation, Laboratory | 1 | 2010 | 7 | 0.090 |
Why?
| | Radiology, Interventional | 1 | 2010 | 28 | 0.090 |
Why?
| | Data Collection | 1 | 2013 | 658 | 0.090 |
Why?
| | Heart | 1 | 2014 | 631 | 0.090 |
Why?
| | Mitral Valve Prolapse | 1 | 2009 | 8 | 0.090 |
Why?
| | Hospitals, Veterans | 1 | 2011 | 246 | 0.090 |
Why?
| | Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2009 | 35 | 0.090 |
Why?
| | Cause of Death | 3 | 2018 | 380 | 0.090 |
Why?
| | Artifacts | 2 | 2009 | 125 | 0.090 |
Why?
| | Cardiovascular Surgical Procedures | 1 | 2009 | 37 | 0.080 |
Why?
| | Patient Reported Outcome Measures | 2 | 2021 | 252 | 0.080 |
Why?
| | Peripheral Vascular Diseases | 1 | 2009 | 98 | 0.080 |
Why?
| | Equipment Failure Analysis | 1 | 2009 | 139 | 0.080 |
Why?
| | Prevalence | 2 | 2018 | 2326 | 0.080 |
Why?
| | Artificial Intelligence | 2 | 2010 | 140 | 0.080 |
Why?
| | Infant, Newborn | 1 | 2019 | 5255 | 0.080 |
Why?
| | Nose | 1 | 2008 | 58 | 0.080 |
Why?
| | Ticlopidine | 1 | 2008 | 61 | 0.080 |
Why?
| | Heart Failure | 2 | 2018 | 1969 | 0.080 |
Why?
| | Robotics | 1 | 2009 | 83 | 0.080 |
Why?
| | Platelet Glycoprotein GPIIb-IIIa Complex | 2 | 2005 | 22 | 0.080 |
Why?
| | Phantoms, Imaging | 2 | 2010 | 139 | 0.080 |
Why?
| | Leg | 1 | 2009 | 234 | 0.080 |
Why?
| | Linear Models | 1 | 2010 | 827 | 0.080 |
Why?
| | Endpoint Determination | 1 | 2008 | 69 | 0.080 |
Why?
| | Wakefulness | 1 | 2008 | 128 | 0.080 |
Why?
| | Motion | 2 | 2010 | 95 | 0.080 |
Why?
| | Sirolimus | 1 | 2009 | 195 | 0.080 |
Why?
| | Cardiac Tamponade | 1 | 2007 | 16 | 0.080 |
Why?
| | Injections | 1 | 2007 | 167 | 0.070 |
Why?
| | Quality Indicators, Health Care | 2 | 2019 | 295 | 0.070 |
Why?
| | Age Factors | 2 | 2020 | 2995 | 0.070 |
Why?
| | Thoracotomy | 1 | 2006 | 84 | 0.070 |
Why?
| | Natriuretic Peptide, Brain | 1 | 2006 | 106 | 0.070 |
Why?
| | Double-Blind Method | 2 | 2008 | 1687 | 0.070 |
Why?
| | Pulmonary Artery | 1 | 2011 | 1063 | 0.070 |
Why?
| | Muramic Acids | 1 | 2004 | 1 | 0.060 |
Why?
| | Acetylmuramyl-Alanyl-Isoglutamine | 1 | 2004 | 14 | 0.060 |
Why?
| | Peptidoglycan | 1 | 2004 | 28 | 0.060 |
Why?
| | Ions | 1 | 2004 | 62 | 0.060 |
Why?
| | Cell Wall | 1 | 2004 | 53 | 0.060 |
Why?
| | Feasibility Studies | 1 | 2007 | 749 | 0.060 |
Why?
| | Open Reading Frames | 1 | 2004 | 121 | 0.060 |
Why?
| | Quality of Life | 3 | 2021 | 2366 | 0.060 |
Why?
| | Probability | 1 | 2005 | 305 | 0.060 |
Why?
| | Whole-Body Irradiation | 1 | 2004 | 72 | 0.060 |
Why?
| | Genome, Bacterial | 1 | 2004 | 109 | 0.060 |
Why?
| | Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2004 | 39 | 0.060 |
Why?
| | Informed Consent | 1 | 2005 | 163 | 0.060 |
Why?
| | Shear Strength | 1 | 2003 | 55 | 0.060 |
Why?
| | Kaplan-Meier Estimate | 2 | 2017 | 842 | 0.060 |
Why?
| | Cloning, Molecular | 1 | 2004 | 546 | 0.060 |
Why?
| | Thrombocytopenia | 1 | 2005 | 185 | 0.060 |
Why?
| | Thrombophilia | 1 | 2004 | 68 | 0.060 |
Why?
| | Diagnosis, Differential | 1 | 2007 | 1384 | 0.060 |
Why?
| | Catheters | 1 | 2023 | 61 | 0.060 |
Why?
| | Diabetes Complications | 1 | 2005 | 218 | 0.060 |
Why?
| | Patient Care Planning | 1 | 2003 | 143 | 0.060 |
Why?
| | Elasticity | 1 | 2003 | 193 | 0.050 |
Why?
| | Numbers Needed To Treat | 1 | 2021 | 8 | 0.050 |
Why?
| | Japan | 1 | 2022 | 97 | 0.050 |
Why?
| | Creatinine | 1 | 2003 | 491 | 0.050 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2009 | 2062 | 0.050 |
Why?
| | Bayes Theorem | 1 | 2023 | 344 | 0.050 |
Why?
| | Curriculum | 1 | 2008 | 910 | 0.050 |
Why?
| | Patient-Centered Care | 1 | 2006 | 497 | 0.050 |
Why?
| | Acute Disease | 1 | 2003 | 940 | 0.050 |
Why?
| | Child | 2 | 2012 | 19129 | 0.050 |
Why?
| | Drug Therapy, Combination | 2 | 2017 | 965 | 0.050 |
Why?
| | Patient Discharge | 2 | 2004 | 796 | 0.050 |
Why?
| | Base Sequence | 1 | 2004 | 2159 | 0.050 |
Why?
| | Florida | 1 | 2020 | 73 | 0.050 |
Why?
| | Escherichia coli | 1 | 2004 | 758 | 0.050 |
Why?
| | Computational Biology | 1 | 2004 | 588 | 0.050 |
Why?
| | Syndrome | 1 | 2021 | 344 | 0.050 |
Why?
| | Population Density | 1 | 2020 | 96 | 0.050 |
Why?
| | Norepinephrine | 1 | 2001 | 212 | 0.050 |
Why?
| | Epinephrine | 1 | 2001 | 167 | 0.040 |
Why?
| | Molecular Sequence Data | 1 | 2004 | 2871 | 0.040 |
Why?
| | Travel | 1 | 2020 | 116 | 0.040 |
Why?
| | Decision Making | 1 | 2006 | 809 | 0.040 |
Why?
| | Cost Savings | 1 | 2019 | 77 | 0.040 |
Why?
| | Cardiac Care Facilities | 1 | 2019 | 14 | 0.040 |
Why?
| | Cardiac Imaging Techniques | 1 | 2019 | 13 | 0.040 |
Why?
| | Credentialing | 1 | 2019 | 12 | 0.040 |
Why?
| | Health Care Surveys | 1 | 2021 | 546 | 0.040 |
Why?
| | Terminology as Topic | 1 | 2020 | 211 | 0.040 |
Why?
| | Trauma Severity Indices | 1 | 2019 | 127 | 0.040 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2001 | 301 | 0.040 |
Why?
| | Models, Econometric | 1 | 2018 | 34 | 0.040 |
Why?
| | Insurance, Health, Reimbursement | 1 | 2019 | 88 | 0.040 |
Why?
| | Renin-Angiotensin System | 1 | 2018 | 82 | 0.040 |
Why?
| | Child, Preschool | 1 | 2012 | 9491 | 0.040 |
Why?
| | Inpatients | 2 | 2016 | 388 | 0.040 |
Why?
| | Residence Characteristics | 1 | 2020 | 299 | 0.040 |
Why?
| | Workload | 1 | 2019 | 128 | 0.040 |
Why?
| | Risk Management | 1 | 2018 | 90 | 0.040 |
Why?
| | Markov Chains | 1 | 2018 | 118 | 0.040 |
Why?
| | Reference Values | 1 | 2019 | 774 | 0.040 |
Why?
| | United Kingdom | 1 | 2018 | 236 | 0.040 |
Why?
| | Intraoperative Complications | 1 | 2018 | 132 | 0.040 |
Why?
| | Altitude | 1 | 2001 | 422 | 0.040 |
Why?
| | Quality Assurance, Health Care | 1 | 2019 | 325 | 0.040 |
Why?
| | Mortality | 1 | 2018 | 299 | 0.040 |
Why?
| | Biomarkers | 1 | 2006 | 3588 | 0.030 |
Why?
| | Renal Dialysis | 1 | 2019 | 378 | 0.030 |
Why?
| | Congresses as Topic | 1 | 2016 | 204 | 0.030 |
Why?
| | Survival Analysis | 1 | 2018 | 1267 | 0.030 |
Why?
| | Models, Theoretical | 1 | 2019 | 556 | 0.030 |
Why?
| | Medicaid | 1 | 2018 | 411 | 0.030 |
Why?
| | Comorbidity | 1 | 2019 | 1527 | 0.030 |
Why?
| | Spatio-Temporal Analysis | 1 | 2014 | 29 | 0.030 |
Why?
| | Venous Thromboembolism | 1 | 2017 | 234 | 0.030 |
Why?
| | Radiation | 1 | 2013 | 26 | 0.030 |
Why?
| | Logistic Models | 1 | 2018 | 1901 | 0.030 |
Why?
| | Constriction, Pathologic | 1 | 2011 | 203 | 0.020 |
Why?
| | Combined Modality Therapy | 2 | 2005 | 1166 | 0.020 |
Why?
| | Exercise | 1 | 2001 | 1657 | 0.020 |
Why?
| | Torsion, Mechanical | 1 | 2009 | 7 | 0.020 |
Why?
| | Patient Satisfaction | 1 | 2013 | 610 | 0.020 |
Why?
| | Radiotherapy Planning, Computer-Assisted | 1 | 2010 | 120 | 0.020 |
Why?
| | Calibration | 1 | 2009 | 135 | 0.020 |
Why?
| | Posture | 1 | 2009 | 158 | 0.020 |
Why?
| | Radiography | 1 | 2010 | 861 | 0.020 |
Why?
| | Myocardial Ischemia | 1 | 2008 | 251 | 0.020 |
Why?
| | Vascular Surgical Procedures | 1 | 2009 | 262 | 0.020 |
Why?
| | Biomechanical Phenomena | 1 | 2009 | 683 | 0.020 |
Why?
| | Platelet Count | 1 | 2005 | 83 | 0.020 |
Why?
| | Age Distribution | 1 | 2005 | 362 | 0.020 |
Why?
| | Sex Distribution | 1 | 2005 | 351 | 0.020 |
Why?
| | Patient Admission | 1 | 2004 | 176 | 0.010 |
Why?
| | Odds Ratio | 1 | 2005 | 996 | 0.010 |
Why?
| | Heparin | 1 | 2003 | 230 | 0.010 |
Why?
| | Myocardial Reperfusion | 1 | 2002 | 53 | 0.010 |
Why?
| | Cross-Over Studies | 1 | 2003 | 456 | 0.010 |
Why?
| | Postoperative Care | 1 | 2003 | 237 | 0.010 |
Why?
| | Prazosin | 1 | 2001 | 22 | 0.010 |
Why?
| | Adrenergic alpha-Agonists | 1 | 2001 | 31 | 0.010 |
Why?
| | Adrenergic alpha-Antagonists | 1 | 2001 | 31 | 0.010 |
Why?
| | Phenylephrine | 1 | 2001 | 85 | 0.010 |
Why?
| | Health Care Costs | 1 | 2003 | 394 | 0.010 |
Why?
| | Oxygen Consumption | 1 | 2001 | 586 | 0.010 |
Why?
|
|
Carroll's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|